Evidence map›Paper›PMID 34782742›Full record

ArticleNature chemical biology2022

A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.

David Dilworth, Ronan P Hanley, Renato Ferreira de Freitas, Abdellah Allali-Hassani, Mengqi Zhou, Naimee Mehta, Matthew R Marunde, Suzanne Ackloo, Raquel Arminda Carvalho Machado, Aliakbar Khalili Yazdi and 30 more

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 3 institutions in 4 countries.

David Dilworth *Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. david.dilworth@utoronto.ca.ORCID http://orcid.org/0000-0001-5557-9476
Ronan P Hanley *Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Renato Ferreira de Freitas *Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Abdellah Allali-Hassani *Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Mengqi Zhou *Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Naimee MehtaCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Matthew R MarundeEpiCypher Inc., Durham, NC, USA.
Suzanne AcklooStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Raquel Arminda Carvalho MachadoStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-5912-2991
Aliakbar Khalili YazdiStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Dominic D G OwensStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Victoria VuStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
David Y NieStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Mona AlqazzazStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Edyta MarconDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Fengling LiStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Irene ChauStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Albina BolotokovaStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Su QinStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Ming LeiStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Yanli LiuStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Magdalena M SzewczykStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Aiping DongStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
Sina KazemzadehCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Tigran AbramyanCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Irina K PopovaEpiCypher Inc., Durham, NC, USA.
Nathan W HallEpiCypher Inc., Durham, NC, USA.
Matthew J MeinersEpiCypher Inc., Durham, NC, USA.
Marcus A CheekEpiCypher Inc., Durham, NC, USA.
Elisa GibsonStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-7112-337X
Dmitri KireevCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-8479-8555
Jack F GreenblattDonnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Michael-C KeoghEpiCypher Inc., Durham, NC, USA.ORCID http://orcid.org/0000-0002-2219-8623
Jinrong MinStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-5210-3130
Peter J BrownStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-8454-0367
Masoud VedadiStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-0574-0169
Cheryl H ArrowsmithStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-4971-3250
Dalia Barsyte-LovejoyStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. d.barsyte@utoronto.ca.ORCID http://orcid.org/0000-0002-6560-9621
Lindsey I JamesCenter for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ingerman@email.unc.edu.ORCID http://orcid.org/0000-0002-6034-7116
Matthieu SchapiraStructural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. matthieu.schapira@utoronto.ca.ORCID http://orcid.org/0000-0002-1047-3309
University of Toronto · CAEpiCypher (United States) · USUniversity of North Carolina at Chapel Hill · US

Funding

High-throughput methyltransferase assays using recombinant nucleosome substratesR44GM117683 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2018 to 2019
$1.7M
DISCOVERY OF FIRST-IN-CLASS NSD2 DEGRADERS FOR CANCER THERAPYR01CA242305 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JAMES, LINDSEY INGERMAN · 2019 to 2024
$1.7M
Barcoded nucleosomes for analyzing combinatorial epigenetic regulatorsR44GM116584 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2017 to 2018
$1.6M
NCI NIH HHS R01 CA242305NIGMS NIH HHS R44 GM116584NIGMS NIH HHS R44 GM117683Wellcome TrustWellcome Trust 106169/ZZ14/Z
6 · The paper itself

Abstract

Nuclear receptor-binding SET domain-containing 2 (NSD2) is the primary enzyme responsible for the dimethylation of lysine 36 of histone 3 (H3K36), a mark associated with active gene transcription and intergenic DNA methylation. In addition to a methyltransferase domain, NSD2 harbors two proline-tryptophan-tryptophan-proline (PWWP) domains and five plant homeodomains (PHDs) believed to serve as chromatin reading modules. Here, we report a chemical probe targeting the N-terminal PWWP (PWWP1) domain of NSD2. UNC6934 occupies the canonical H3K36me2-binding pocket of PWWP1, antagonizes PWWP1 interaction with nucleosomal H3K36me2 and selectively engages endogenous NSD2 in cells. UNC6934 induces accumulation of endogenous NSD2 in the nucleolus, phenocopying the localization defects of NSD2 protein isoforms lacking PWWP1 that result from translocations prevalent in multiple myeloma (MM). Mutations of other NSD2 chromatin reader domains also increase NSD2 nucleolar localization and enhance the effect of UNC6934. This chemical probe and the accompanying negative control UNC7145 will be useful tools in defining NSD2 biology.

Indexed as

Protein DomainsCell NucleolusHistone-Lysine N-MethyltransferaseMethylationMolecular ProbesMultiple MyelomaNucleosomesRepressor ProteinsHistone-Lysine N-MethyltransferaseMolecular ProbesNSD2 protein, humanNucleosomesRepressor Proteins

Identifiers

PMID34782742
PMCPMC9189931
OpenAlexW3214477352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.